Cargando…

Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature

BACKGROUND: The aim of this study was to highlight the clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma (PPAFH) to assist with a differential diagnosis. METHODS: There were 10 previous reports in the literature and four new PPAFH cases reviewed in this study. Immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Zhang, Liping, Ren, Li, Liu, Dongge, Du, Jun, Zhang, Min, Lou, Ge, Song, Ying, Wang, Yin, Wu, Chunyan, Han, Guiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862796/
https://www.ncbi.nlm.nih.gov/pubmed/33314685
http://dx.doi.org/10.1111/1759-7714.13727
_version_ 1783647367902265344
author Wang, Zheng
Zhang, Liping
Ren, Li
Liu, Dongge
Du, Jun
Zhang, Min
Lou, Ge
Song, Ying
Wang, Yin
Wu, Chunyan
Han, Guiping
author_facet Wang, Zheng
Zhang, Liping
Ren, Li
Liu, Dongge
Du, Jun
Zhang, Min
Lou, Ge
Song, Ying
Wang, Yin
Wu, Chunyan
Han, Guiping
author_sort Wang, Zheng
collection PubMed
description BACKGROUND: The aim of this study was to highlight the clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma (PPAFH) to assist with a differential diagnosis. METHODS: There were 10 previous reports in the literature and four new PPAFH cases reviewed in this study. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) and DNA and RNA‐based next‐generation sequencing (NGS) was performed in the four new cases reported here. RESULTS: In the four new PPAFH cases, the ages of occurrence were in patients age from 33 to 55 years and tumor sizes were from 1.5 to 8 cm. Three of four (75.0%) tumors were located in the endobronchus. The most common morphological changes included delineated fibrous capsule (100%, 4/4), lymphoplasmacytic cuff (100%, 4/4), and dense or richly lymphoplasmatic infiltration (100%, 4/4). IHC analysis revealed that the tumor cells of four cases expressed vimentin and TLE1, ALK and CD163 or CD68 was positive in three cases, epithelial membrane antigen (EMA), desmin was positive in two cases, and SMA focal positive expression was observed in two cases. EWSR1 gene rearrangement was positive in all PPAFH cases (100%, 4/4) by FISH detections and four cases were confirmed as EWSR1‐CREB1 fusion variant by DNA and RNA based NGS. No regional lymph nodes and distal metastasis, recurrences and death of disease after surgical excision were recorded in all four cases. CONCLUSIONS: PPAFH is a very unusual pulmonary primary mesenchymal tumor and the clinicopathological features are like other unusual sites counterparts, but with a smaller tumor size, related with large airway, with a tendency to exhibit benign biological behavior, with EWSR1 gene rearrangement and higher frequency of EWSR1‐CREB1 gene fusion. KEY POINTS: Significant findings in the study: In comparison with “classic somatic” and nonpulmonary visceral angiomatoid fibrous histiocytoma, pulmonary primary angiomatoid fibrous histiocytoma display distinct clinicopathological features and prognosis. What this study adds The study provided the pathological differential diagnostic criteria and clinico‐pathological features for pulmonary primary angiomatoid fibrous histiocytoma.
format Online
Article
Text
id pubmed-7862796
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-78627962021-02-16 Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature Wang, Zheng Zhang, Liping Ren, Li Liu, Dongge Du, Jun Zhang, Min Lou, Ge Song, Ying Wang, Yin Wu, Chunyan Han, Guiping Thorac Cancer Original Articles BACKGROUND: The aim of this study was to highlight the clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma (PPAFH) to assist with a differential diagnosis. METHODS: There were 10 previous reports in the literature and four new PPAFH cases reviewed in this study. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) and DNA and RNA‐based next‐generation sequencing (NGS) was performed in the four new cases reported here. RESULTS: In the four new PPAFH cases, the ages of occurrence were in patients age from 33 to 55 years and tumor sizes were from 1.5 to 8 cm. Three of four (75.0%) tumors were located in the endobronchus. The most common morphological changes included delineated fibrous capsule (100%, 4/4), lymphoplasmacytic cuff (100%, 4/4), and dense or richly lymphoplasmatic infiltration (100%, 4/4). IHC analysis revealed that the tumor cells of four cases expressed vimentin and TLE1, ALK and CD163 or CD68 was positive in three cases, epithelial membrane antigen (EMA), desmin was positive in two cases, and SMA focal positive expression was observed in two cases. EWSR1 gene rearrangement was positive in all PPAFH cases (100%, 4/4) by FISH detections and four cases were confirmed as EWSR1‐CREB1 fusion variant by DNA and RNA based NGS. No regional lymph nodes and distal metastasis, recurrences and death of disease after surgical excision were recorded in all four cases. CONCLUSIONS: PPAFH is a very unusual pulmonary primary mesenchymal tumor and the clinicopathological features are like other unusual sites counterparts, but with a smaller tumor size, related with large airway, with a tendency to exhibit benign biological behavior, with EWSR1 gene rearrangement and higher frequency of EWSR1‐CREB1 gene fusion. KEY POINTS: Significant findings in the study: In comparison with “classic somatic” and nonpulmonary visceral angiomatoid fibrous histiocytoma, pulmonary primary angiomatoid fibrous histiocytoma display distinct clinicopathological features and prognosis. What this study adds The study provided the pathological differential diagnostic criteria and clinico‐pathological features for pulmonary primary angiomatoid fibrous histiocytoma. John Wiley & Sons Australia, Ltd 2020-12-12 2021-02 /pmc/articles/PMC7862796/ /pubmed/33314685 http://dx.doi.org/10.1111/1759-7714.13727 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Wang, Zheng
Zhang, Liping
Ren, Li
Liu, Dongge
Du, Jun
Zhang, Min
Lou, Ge
Song, Ying
Wang, Yin
Wu, Chunyan
Han, Guiping
Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title_full Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title_fullStr Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title_full_unstemmed Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title_short Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature
title_sort distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: a report of four new cases and review of the literature
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862796/
https://www.ncbi.nlm.nih.gov/pubmed/33314685
http://dx.doi.org/10.1111/1759-7714.13727
work_keys_str_mv AT wangzheng distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT zhangliping distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT renli distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT liudongge distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT dujun distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT zhangmin distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT louge distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT songying distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT wangyin distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT wuchunyan distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature
AT hanguiping distinctclinicopathologicalfeaturesofpulmonaryprimaryangiomatoidfibroushistiocytomaareportoffournewcasesandreviewoftheliterature